Raging bull' - Vaccines don’t cause autism and saying otherwise costs lives
Vaccines do not cause autism and people who say otherwise are wrong.
Archives for February 22, 2017
iCardiac eCOA platform a 'major step forward,' says CEO
iCardiac’s new eCOA platform, QPoint, can measure clinical outcome assessments from patients at home or during site visits and will soon integrate with emerging wearables.
Modus raises cash for Ph II trial of Sickle Cell drug in EU, Middle East and Caribbean
Modus Therapeutics AB has raised an additional 32m SEK (£2.85m) for its Phase II trial for pain crises in Sickle Cell Disease, running in the Caribbean, Middle East and Europe.
Evotec taps into Oxford innovation through £13m grant scheme
Dubbed LAB282, the £13m (€15M) Oxford University drug discovery program with Evotec has announced two grant winners and a second set of awards of up to £250,000.
Bioclinica: more stakeholders pushes need for collaboration
Bioclinica has expanded its eHealth App xChange to make a greater range of technologies available to the increasing number of industry stakeholders – many with differing priorities.
Momenta says Pfizer will fix plant but reiterates that Glatopa 40mg ANDA delay likely
Momenta Pharmaceuticals has reiterated its belief that problems at a US Pfizer plant mean the FDA is unlikely to reach a decision on its 40mg version of Teva’s Copaxone before April.